The global cognition and memory enhancement market size was US$ 5,348.9 million in 2021. The global cognition and memory enhancement market size is forecast to reach US$ 8,513.8 million by 2030, growing at a compound annual growth rate (CAGR) of 5.3% during the forecast period from 2022 to 2030.
Supplements or drugs that increase cognitive function include cognitive and memory enhancers. Individuals with schizophrenia, stroke, Alzheimer's disease, attention deficit hyperactivity disorder (ADHD), or elderly patients are most frequently treated with these.
Factors Influencing Market Growth
The growing geriatric population and the rise in the number of neurological and memory-related problems drive the global market. According to the WHO estimation, more than 46 million people have dementia, which is a significant factor impacting this market's growth.
The continuing clinical trials and potential drugs in the pipeline boost the global market growth.
The ethical problems related to the use of these drugs may slow down the overall market growth.
The rising healthcare professionals' awareness of neurodegenerative disorders fuels global market growth.
The increasing demand for improved brain health and mental fitness is forecast to offer lucrative opportunities for the global market during the forecast period.
Impact Analysis of COVID-19
The COVID-19 pandemic had a negative impact on the global cognitive and memory enhancement market. Several governments worldwide imposed a lockdown in order to curb the virus from spreading. The demand for cognitive and enhancer medications decreased due to the decrease in hospital and clinic visits for the treatment of neurodegenerative disorders; these drugs are largely employed in the treatment of neurodegenerative disorders. However, the market is anticipated to reach its full potential in the future thanks to continued immunizations and a decline in COVID-19 cases.
Regional Analysis
North America garnered a substantial market share in 2021 and is forecast to remain dominant during the forecast period. As a result of the high provisions for cognitive enhancement training solutions offered by established players. In addition, the increased burden of Alzheimer's disease, an geriatric population, a substantial rise in investment in research and development, and the advent of new products in the region.
The Asia Pacific region is forecast to have considerable growth during the forecast period. As a result of the rising prevalence of neurological disorders and the existence of a large patient pool.
Leading Competitors
The leading prominent companies profiled in the global cognition and memory enhancement market are:
Eisai Co., Ltd
Johnson & Johnson Services, Inc
Nordic Naturals
Takeda Pharmaceutical Company Ltd.
Natrol, LLC
Cambridge Cognition Ltd.
Biogen Inc
Eli Lilly and Company
Cogstate Ltd
Teva Pharmaceutical Industries Ltd. (Cephalon Inc.)
Other Prominent Players
Scope of the Report
The global cognition and memory enhancement market segmentation focuses on Product, Application, and Region.
Segmentation based on Product
Aricept
Exelon
Namenda
Razadyne
Provigill
Ritalin
Adderall
Others
Segmentation based on Application
Disease Treatment
Education
o Sports
o Others
Segmentation based on Region
North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America
Meta Title: Cognition and Memory enhancement Market Size, Share, Insight, and Forecast 2022 to 2030
Meta Description: Global Cognition and Memory enhancement Market is projected to reach US$ 8,513.8 million by the end of 2030 from US$ 5,348.9 million in 2021, at a CAGR of 5.3%
Meta Keywords: cognition and memory enhancement market Size, cognition and memory enhancement market share, cognition and memory enhancement market trend, cognition and memory enhancement market Forecast, cognition and memory enhancement market insight